Signs of Alzheimer's disease may be detectable before significant symptoms are obvious

by University of GlasgowCredit: Pixabay/CC0 Public DomainHealthy people with a higher genetic risk of Alzheimer's disease may show differences in brain structure and in cognitive test scores

Updated on: April 08,2024

Signs of Alzheimer's disease may be detectable before significant symptoms are obvious

by University of GlasgowCredit: Pixabay/CC0 Public DomainHealthy people with a higher genetic risk of Alzheimer's disease may show differences in brain structure and in cognitive test scores

Updated on:April 08,2024

Dementia screening test adapted for people with hearing problems

by University of QueenslandReceiver operating characteristic (ROC) curve analysis of the Montreal Cognitive Assessment for people with hearing impairment (MoCA-H), with and without adjustment for

Updated on: May 11,2024

Dementia screening test adapted for people with hearing problems

by University of QueenslandReceiver operating characteristic (ROC) curve analysis of the Montreal Cognitive Assessment for people with hearing impairment (MoCA-H), with and without adjustment for

Updated on:May 11,2024

These are the three big factors driving strokes, experts warn

by Dennis ThompsonA trio of risk factors not only increase your risk of stroke, but they also raise the odds that such a stroke will be debilitating, a new study warns.What are these three big dangers

Updated on: November 27,2024

These are the three big factors driving strokes, experts warn

by Dennis ThompsonA trio of risk factors not only increase your risk of stroke, but they also raise the odds that such a stroke will be debilitating, a new study warns.What are these three big dangers

Updated on:November 27,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on: April 16,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on:April 16,2024

Research to tackle the triple challenge of dementia, hearing and vision impairment

by University of ManchesterThe combined impact of dementia, age-related hearing and vision impairment is to be investigated by a new multi-million European research consortium led by The Universi

Updated on: February 28,2024

Research to tackle the triple challenge of dementia, hearing and vision impairment

by University of ManchesterThe combined impact of dementia, age-related hearing and vision impairment is to be investigated by a new multi-million European research consortium led by The Universi

Updated on:February 28,2024

No clinical symptoms in study of Alzheimer's transmissibility

by Medical University of ViennaMedUni Vienna researchers have published the results of a clarifying research study on the potential transmissibility of Alzheimer's disease. Although the prote

Updated on: February 28,2024

No clinical symptoms in study of Alzheimer's transmissibility

by Medical University of ViennaMedUni Vienna researchers have published the results of a clarifying research study on the potential transmissibility of Alzheimer's disease. Although the prote

Updated on:February 28,2024

Greater abdominal aortic calcification ups dementia risk in older women

Older women with more advanced abdominal aortic calcification (AAC) have a higher risk for late-life dementia, according to a study published online June 26 inThe Lancet Regional Health: Western

Updated on: May 13,2024

Greater abdominal aortic calcification ups dementia risk in older women

Older women with more advanced abdominal aortic calcification (AAC) have a higher risk for late-life dementia, according to a study published online June 26 inThe Lancet Regional Health: Western

Updated on:May 13,2024

Estrogen drug may not benefit women with Alzheimer's dementia

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.An estrogen-like drug, raloxifene, has no demonstrated benefit on me

Updated on: February 26,2024

Estrogen drug may not benefit women with Alzheimer's dementia

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.An estrogen-like drug, raloxifene, has no demonstrated benefit on me

Updated on:February 26,2024

Identification of a central regulator

by Ludwig Maximilian University of MunichC1q (green) and ApoE (red) proteins form deposits in the choroid plexus, as the researchers revealed by super-resolution microscopy. Bar 1 µm. Credit: C.

Updated on: March 09,2024

Identification of a central regulator

by Ludwig Maximilian University of MunichC1q (green) and ApoE (red) proteins form deposits in the choroid plexus, as the researchers revealed by super-resolution microscopy. Bar 1 µm. Credit: C.

Updated on:March 09,2024

A new biomarker of brain inflammation in early-stage Alzheimer's disease

by European Molecular Biology OrganizationResearchers at the Ludwig-Maximilians-University, the German Center for Neurodegenerative Diseases (DZNE), and the Institute for Stroke and Dementia Rese

Updated on: February 28,2024

A new biomarker of brain inflammation in early-stage Alzheimer's disease

by European Molecular Biology OrganizationResearchers at the Ludwig-Maximilians-University, the German Center for Neurodegenerative Diseases (DZNE), and the Institute for Stroke and Dementia Rese

Updated on:February 28,2024

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on: February 28,2024

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on:February 28,2024

Uncovering factors that drive depression after a stroke

byGeorgetown University Medical CenterCredit: Unsplash/CC0 Public DomainAfter a stroke, many people develop depression that is driven by factors including cognitive difficulties, a lack of socia

Updated on: November 06,2024

Uncovering factors that drive depression after a stroke

byGeorgetown University Medical CenterCredit: Unsplash/CC0 Public DomainAfter a stroke, many people develop depression that is driven by factors including cognitive difficulties, a lack of socia

Updated on:November 06,2024